🔎 Trials Near Me

Beranda › Gagal Ginjal › Illinois

Uji klinis Gagal Ginjal di Illinois

7 studi untuk Gagal Ginjal mencari peserta di lokasi di Illinois.

Kota di Illinois

Teks studi resmi (Bahasa Inggris)

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  • Research Site, Chicago
  • Research Site, Chicago
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06749457

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

  • Northwestern Memorial Hospital, Chicago
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT06552169

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  • Northwestern University, Chicago
Menerima peserta
Usia 18 hingga 84 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06190717

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

  • Northwestern Memorial Hospital, Chicago
Menerima pesertaFase 1/2
Usia 40 hingga 70 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06878560

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Northwestern University Feinberg School of Medicine, Chicago
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

  • Northwestern University, Chicago
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT07059962

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

  • Rush University Medical Center, Chicago
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Nov 2025 · NCT03803423

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.